EcoDrugPlus

Ensembl ID : ENSLBEG00000005563
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSLBEG00000025994
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSLBEG00000027837
Gene Symbol: -
Cross references: -
4 Possible Orthologues:

Ensembl ID : ENSLBEG00000003337
Gene Symbol: -
Cross references: -
32 Possible Orthologues:

Ensembl ID : ENSLBEG00000028146
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSLBEG00000002844
Gene Symbol: -
Cross references: -
182 Possible Orthologues:

Ensembl ID : ENSLBEG00000021796
Gene Symbol: -
Cross references: -
153 Possible Orthologues:

Ensembl ID : ENSLBEG00000004446
Gene Symbol: -
Cross references: -
168 Possible Orthologues:

Ensembl ID : ENSLBEG00000020562
Gene Symbol: -
Cross references: -
533 Possible Orthologues:

Ensembl ID : ENSLBEG00000009515
Gene Symbol: -
Cross references: -
127 Possible Orthologues:

Ensembl ID : ENSLBEG00000006282
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSLBEG00000021956
Gene Symbol: RXRAA
1 Cross references
225 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).